Compare Stocks: VRAX vs. DCOY vs. GRI vs. JAGX
Compare normalized stock price performance over 6 months, 1 year or 2 years. Each line starts at 0%, so different stock prices can be compared on the same scale.
VRAXDCOYGRIJAGX
Market Snapshot
Current market context for the selected companies.
VRAX
$2.99
Market Cap
$2.54M
Sector
Healthcare
Industry
Biotechnology
Data through
2026-08-24
DCOY
$3.21
Market Cap
$2.10M
Sector
Healthcare
Industry
Biotechnology
Data through
2026-08-24
GRI
$1.76
Market Cap
$3.61M
Sector
Healthcare
Industry
Biotechnology
Data through
2026-08-24
JAGX
$0.92
Market Cap
$4.26M
Sector
Healthcare
Industry
Biotechnology
Data through
2026-08-24
Performance
Absolute returns and relative performance versus SPY.
| Metric | VRAX | DCOY | GRI | JAGX |
|---|---|---|---|---|
| 1 Month | -6.3% | -36.2% | +21.3% | -4.2% |
| 1 Month vs SPY | -9.6% | -39.5% | +18.0% | -7.5% |
| 3 Months | -57.0% | -56.0% | -14.6% | -68.3% |
| 3 Months vs SPY | -59.4% | -58.4% | -17.0% | -70.7% |
| 6 Months | -41.9% | -61.8% | -24.5% | -95.8% |
| 6 Months vs SPY | -53.8% | -73.7% | -36.4% | -107.7% |
| 1 Year | -83.9% | -95.0% | -95.5% | -98.6% |
| 1 Year vs SPY | -104.0% | -115.1% | -115.6% | -118.7% |
| 2 Years | -97.7% | -99.1% | -99.3% | -99.9% |
| 2 Years vs SPY | -134.1% | -135.5% | -135.7% | -136.3% |
Growth & Profitability
Operating growth, margins and capital efficiency.
Valuation
Common valuation multiples shown side by side.
Cash Flow & Balance Sheet
Cash generation and leverage context.
Earnings Outlook
Upcoming earnings expectations when available.